← Browse by Condition
Medical Condition

healthy volunteers hv

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1

Clinical trials often recruit healthy volunteers for Phase 1 pharmacokinetic and safety studies, vaccine immunogenicity assessments, and normal physiological reference studies. These trials are essential for establishing safe dose ranges and understanding how drugs behave in the absence of disease before testing in patient populations.

Healthy volunteer studies include first-in-human drug trials, vaccine efficacy (flu, RSV, COVID-19, malaria), microbiome intervention studies, exercise physiology research, and device safety assessments. Compensation is often provided; eligibility typically requires no significant medical history and a negative drug screen.

Healthy volunteer trials require participants to be in good general health with no significant medications. Many exclude smokers, pregnant individuals, and those with recent prior trial participation.

Frequently Asked Questions — healthy volunteers hv Clinical Trials

How many clinical trials are currently recruiting for healthy volunteers hv?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for healthy volunteers hv, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for healthy volunteers hv?
healthy volunteers hv research spans Phase 1 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a healthy volunteers hv clinical trial?
Eligibility criteria for healthy volunteers hv trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Top Sponsors
Vertero Therapeutics 1 trial
University of Maryland, Baltimore 1 trial
Helixon Biotechnology (Suzhou) Co., Ltd 1 trial

Recruiting Clinical Trials

NCT07310264 Phase 1
Recruiting
Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease
Enrollment
84 pts
Location
Netherlands
Sponsor
Vertero Therapeutics
View Trial →
NCT07008664
Recruiting
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer
Enrollment
750 pts
Location
United States
Sponsor
University of Maryland, Baltim...
View Trial →
NCT07449741 Phase 1
Recruiting
Phase I Study of HXN6005 in Adult Healthy Participants
Enrollment
32 pts
Location
Australia
Sponsor
Helixon Biotechnology (Suzhou)...
View Trial →

Related Conditions

parkinson s disease pd (1) lung cancer (1) lung cancer screening (1) unhealthy volunteers (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology